Contact
Please use this form to send email to PR contact of this press release:
Athenex Announces U.S. FDA Allowance of Investigational New Drug Application for PT01 (Pegtomarginase)
TO:
Please use this form to send email to PR contact of this press release:
Athenex Announces U.S. FDA Allowance of Investigational New Drug Application for PT01 (Pegtomarginase)
TO: